New research has concluded that golden nanoparticles help lose fat in mice without losing muscle mass, but more investigations are needed before the technique can be applied to humans.
A new published in the journal Science Reports made by scientists at the University of Alexandria, Egypt, suggests that gold nanoparticles (Aunps) can be an innovative approach to LOSS OF GUIDED FATwithout muscle loss associated with medicines for GLP-1 weight loss.
The results indicate potential weight loss benefits that exceed current treatments, along with anti-inflammatory advantages and glucose regulation, explains.
The investigation, carried out in diet -induced obese rats, showed that high -weekly doses of Aunps led to a Average reduction of 36% of fat body over nine weeks. This is favorably compared to 10-20% weight loss observed with GLP-1 medications, which often result in muscle loss. In addition, Aunps improved metabolic markers and repaired liver and kidney tissue, while Orlistat (a normally used weight loss drug) showed adverse effects on these organs.
The study evaluated different Aunp dosage regimes in relation to a group of control and orlistrate treatment. The results indicated that the High weekly doses were the most effectiveproducing greater impact than daily administration. Through bioelectric impedance analysis (BIA), researchers confirmed that Aunps specifically aimed at lipid cells, significantly improving fat -free mass.
Despite promising results, humans’ rehearsals remain a challenge due to potential toxicity concerns. Aunps are already used in Treatments against cancer And in drug administration, but further investigation is required to evaluate long -term safety and effectiveness in the treatment of obesity.
Although comparisons with GLP-1 medicines have not yet been tested, the nature of muscle preservation of Aunps suggests that they could complement the existing treatments instead of replacing them.
